Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "Business"

2437 News Found

Redcliffe Labs appoints Vijay T. S. as Chief People Officer
People | June 01, 2026

Redcliffe Labs appoints Vijay T. S. as Chief People Officer

Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments


AstraZeneca's India revenue climbs 33% YoY to Rs. 22.76 billion in FY26
News | June 01, 2026

AstraZeneca's India revenue climbs 33% YoY to Rs. 22.76 billion in FY26

While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications


Takeda promotes Garima Srivastava as VP HR, Global Head of Talent Acquisition for Commercial
People | June 01, 2026

Takeda promotes Garima Srivastava as VP HR, Global Head of Talent Acquisition for Commercial

Seasoned HR leader brings over 15 years of experience in global talent strategy, organizational transformation, and workforce planning


Sanofi brings AI-driven rare disease diagnostic tool AccelRare to India
Digitisation | June 01, 2026

Sanofi brings AI-driven rare disease diagnostic tool AccelRare to India

Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device


FDA greenlights AstraZeneca’s Imfinzi combo in bladder cancer breakthrough
R&D | May 30, 2026

FDA greenlights AstraZeneca’s Imfinzi combo in bladder cancer breakthrough

The study tracked patients for more than five years (median 60.7 months), with protection against disease returning emerging in under four months and continuing long term


Alkem Labs posts highest-ever EBITDA in FY26; Q4 revenue rises 14.6%
News | May 29, 2026

Alkem Labs posts highest-ever EBITDA in FY26; Q4 revenue rises 14.6%

Strong domestic and international growth, improving product mix, and operational efficiencies drive margin expansion despite exceptional charges impacting quarterly profit


Abbott secures CE mark for first dual glucose-ketone monitoring systems
Medical Device | May 29, 2026

Abbott secures CE mark for first dual glucose-ketone monitoring systems

Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk


India’s MedTech industry is entering its defining decade: Dr. Shravan Subramanyam, MD, BPL Medical Technologies
Opinion | May 29, 2026

India’s MedTech industry is entering its defining decade: Dr. Shravan Subramanyam, MD, BPL Medical Technologies

From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies